235 related articles for article (PubMed ID: 1716596)
1. Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis.
Kettel LM; Murphy AA; Mortola JF; Liu JH; Ulmann A; Yen SS
Fertil Steril; 1991 Sep; 56(3):402-7. PubMed ID: 1716596
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids.
Kettel LM; Murphy AA; Morales AJ; Yen SS
Hum Reprod; 1994 Jun; 9 Suppl 1():116-20. PubMed ID: 7962456
[TBL] [Abstract][Full Text] [Related]
3. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
4. Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486).
Kettel LM; Murphy AA; Morales AJ; Yen SS
Am J Obstet Gynecol; 1998 Jun; 178(6):1151-6. PubMed ID: 9662295
[TBL] [Abstract][Full Text] [Related]
5. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
6. Endometrial effects of long-term low-dose administration of RU486.
Murphy AA; Kettel LM; Morales AJ; Roberts V; Parmley T; Yen SS
Fertil Steril; 1995 Apr; 63(4):761-6. PubMed ID: 7890059
[TBL] [Abstract][Full Text] [Related]
7. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
8. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
9. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
10. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
11. Treatment of endometriosis with the antiprogesterone mifepristone (RU486).
Kettel LM; Murphy AA; Morales AJ; Ulmann A; Baulieu EE; Yen SS
Fertil Steril; 1996 Jan; 65(1):23-8. PubMed ID: 8557150
[TBL] [Abstract][Full Text] [Related]
12. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
[TBL] [Abstract][Full Text] [Related]
13. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
[TBL] [Abstract][Full Text] [Related]
14. Response to intermittent RU486 in women.
Spitz IM; Croxatto HB; Salvatierra AM; Heikinheimo O
Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
[TBL] [Abstract][Full Text] [Related]
15. Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect.
Murphy AA; Morales AJ; Kettel LM; Yen SS
Fertil Steril; 1995 Jul; 64(1):187-90. PubMed ID: 7789557
[TBL] [Abstract][Full Text] [Related]
16. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
[TBL] [Abstract][Full Text] [Related]
17. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
18. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
[TBL] [Abstract][Full Text] [Related]
20. RU486: pharmacology and potential use in the treatment of endometriosis and leiomyomata uteri.
Murphy AA; Castellano PZ
Curr Opin Obstet Gynecol; 1994 Jun; 6(3):269-78. PubMed ID: 8038415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
